Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD93 is a C-type lectin transmembrane glycoprotein receptor involved in cell adhesion, host defense, angiogenesis, phagocytosis, and immune regulation. It is expressed on endothelial cells, myeloid cells, and hematopoietic stem cells, and exists in both membrane-bound and soluble forms. CD93 plays a role in various diseases, including cancer, glioma, acute myeloid leukemia, and psoriasis, making it a potential therapeutic target.
Unknown, targets in development
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD93 molecule (CD93).